1. Home
  2. CNTX vs RNGT Comparison

CNTX vs RNGT Comparison

Compare CNTX & RNGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$2.25

Market Cap

283.9M

Sector

Health Care

ML Signal

HOLD

RNGT

Range Capital Acquisition Corp II Class A Ordinary Shares

N/A

Current Price

$10.04

Market Cap

313.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CNTX
RNGT
Founded
2015
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.9M
313.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CNTX
RNGT
Price
$2.25
$10.04
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$6.60
N/A
AVG Volume (30 Days)
747.3K
19.0K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
17.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$9.90
52 Week High
$3.62
$10.05

Technical Indicators

Market Signals
Indicator
CNTX
RNGT
Relative Strength Index (RSI) 41.64 61.75
Support Level $2.07 $9.95
Resistance Level $2.58 N/A
Average True Range (ATR) 0.19 0.01
MACD -0.03 0.00
Stochastic Oscillator 12.10 83.33

Price Performance

Historical Comparison
CNTX
RNGT

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About RNGT Range Capital Acquisition Corp II Class A Ordinary Shares

Range Capital Acquisition Corp II is a blank check company.

Share on Social Networks: